New strain of bird flu found; Panacea inks $35M vaccines deal;

Vaccine Research

A new strain of bird flu has been discovered in Nigeria. Report

BN ImmunoTherapeutics has forged a scientific partnership with the National Cancer Institute in the United States. Under the Cooperative Research and Development Agreement, the NCI and BN ImmunoTherapeutics will jointly develop new therapeutic vaccines for prostate cancer. Release

The International AIDS Vaccine Initiative along with the ICMR and NACO is planning to conduct Phase I HIV prime-boost vaccine trials in Chennai and Pune. Report

Medicago will be presenting an update of its development of H5N1 vaccines generated from plant-made VLPs and unique technology platform at the Targeted Immunotherapeutics and Vaccine Summit. Release

Vaccine Market

Australia's CSL, which makes plasma products as well as vaccines, struck a deal to buy Talecris for $3.1 billion. Report

Panacea Biotech has signed a $35 million deal with Unicef to supply Pentavalent vaccines. Story

Alabama-based Vaxin, which is developing needle-free vaccines, appointed Bill Enright as its new CEO. Report

Federal investigators say that intense criticism of the country's anthrax vaccine prompted Bruce Ivins to launch deadly anthrax attacks against politicians and media figures. Article

Suggested Articles

Sanofi didn't hesitate to enter Zika vaccine R&D, and despite the associated scandal, the company is again jumping into emerging disease vaccine R…

NIH and Moderna will need a coronavirus vaccine manufacturer, and and no major pharmaceutical company has stepped up.

GlaxoSmithKline’s vaccines unit has been a bright spot for the company, but its performance doesn’t make it immune to staff cuts.